Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 15.73% is in line with its 5-year average of 15.70%, near the high end of its 5-year range (-1.55%–19.23%).
1.24% above its 12-month average of 15.54%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 14.98%.
OPERATING MARGIN
15.73%
OPERATING MARGIN AVG TTM
15.54%
OPERATING MARGIN AVG 3Y
16.22%
OPERATING MARGIN AVG 5Y
15.70%
OPERATING MARGIN AVG 10Y
14.69%
OPERATING MARGIN AVG 15Y
16.56%
OPERATING MARGIN AVG 20Y
18.72%
CURRENT VS TTM AVG
+1.24%
CURRENT VS 3Y AVG
-2.99%
CURRENT VS 5Y AVG
+0.22%
CURRENT VS 10Y AVG
+7.08%
CURRENT VS 15Y AVG
-5.03%
CURRENT VS 20Y AVG
-15.95%
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+5.57%
vs the sector median at left
Zimmer Biomet Holdings, Inc.
Market Cap
$18.45B
Operating Margin
15.73%
TTM Avg
15.54%
3Y Avg
16.22%
5Y Avg
15.70%
Market Cap
$17.09B
Operating Margin
20.97%
TTM Avg
21.16%
3Y Avg
19.82%
5Y Avg
19.12%
Market Cap
$21.00B
Operating Margin
44.49%
TTM Avg
47.77%
3Y Avg
49.26%
5Y Avg
45.01%
Market Cap
$15.38B
Operating Margin
24.99%
TTM Avg
19.38%
3Y Avg
20.05%
5Y Avg
20.47%
Market Cap
$14.67B
Operating Margin
39.88%
TTM Avg
32.73%
3Y Avg
24.94%
5Y Avg
21.46%
Market Cap
$13.64B
Operating Margin
-19.76%
TTM Avg
-59.77%
3Y Avg
-59.80%
5Y Avg
-72.77%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. (ZBH) | $18.45B | 15.73% | 15.54% | 16.22% | 15.70% |
| Viatris Inc. (VTRS)vs › | $19.74B | -18.62% | -9.28% | -0.91% | -0.93% |
| Medpace Holdings, Inc. (MEDP)vs › | $17.09B | 20.97% | 21.16% | 19.82% | 19.12% |
| STERIS plc (STE)vs › | $19.98B | 18.91% | 17.21% | 17.04% | 16.18% |
| Revvity, Inc. (RVTY)vs › | $16.00B | 12.32% | 13.70% | 16.38% | 21.25% |
| United Therapeutics Corporation (UTHR)vs › | $21.00B | 44.49% | 47.77% | 49.26% | 45.01% |
| Solventum Corporation (SOLV)vs › | $15.38B | 24.99% | 19.38% | 20.05% | 20.47% |
| Exelixis, Inc. (EXEL)vs › | $14.67B | 39.88% | 32.73% | 24.94% | 21.46% |
| Tempus AI, Inc. (TEM)vs › | $13.64B | -19.76% | -59.77% | -59.80% | -72.77% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.39B | 12.35% | 9.13% | 12.39% | 13.51% |
Gross Margin
61.6%
Operating Margin
15.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 14.98% |
| 2026-03-31 | 17.88% |
| 2025-12-31 | 12.83% |
| 2025-09-30 | 17.55% |
| 2025-06-30 | 14.44% |
| 2025-03-31 | 15.31% |
| 2024-12-31 | 19.23% |
| 2024-09-30 | 15.32% |
| 2024-06-30 | 18.09% |
| 2024-03-31 | 14.07% |
| 2023-12-31 | 18.26% |
| 2023-09-30 | 15.20% |
| 2023-06-30 | 17.63% |
| 2023-03-31 | 17.88% |
| 2022-12-31 | -1.55% |
| 2022-09-30 | 14.69% |
| 2022-06-30 | 15.76% |
| 2022-03-31 | 11.93% |
| 2021-12-31 | 3.88% |
| 2021-09-30 | 14.42% |
| 2021-06-30 | 12.75% |
| 2021-03-31 | 16.15% |
| 2020-12-31 | 11.54% |
| 2020-09-30 | 15.51% |
| 2020-06-30 | -14.00% |
| 2020-03-31 | -25.56% |
| 2019-12-31 | 15.84% |
| 2019-09-30 | 12.99% |
| 2019-06-30 | 10.29% |
| 2019-03-31 | 17.73% |
| 2018-12-31 | -38.17% |
| 2018-09-30 | 12.16% |
| 2018-06-30 | 14.74% |
| 2018-03-31 | 15.12% |
| 2017-12-31 | -1.83% |
| 2017-09-30 | 11.65% |
| 2017-06-30 | 14.37% |
| 2017-03-31 | 17.65% |
| 2016-12-31 | 9.11% |
| 2016-09-30 | 10.67% |
| 2016-06-30 | 10.42% |
| 2016-03-31 | 12.89% |
| 2015-12-31 | 11.04% |
| 2015-09-30 | 6.58% |
| 2015-06-30 | -11.31% |
| 2015-03-31 | 23.79% |
| 2014-12-31 | 18.46% |
| 2014-09-30 | 23.07% |
| 2014-06-30 | 22.06% |
| 2014-03-31 | 25.84% |
| 2013-12-31 | 25.41% |
| 2013-09-30 | 19.71% |
| 2013-06-30 | 17.99% |
| 2013-03-31 | 26.18% |
| 2012-12-31 | 16.98% |
| 2012-09-30 | 24.32% |
| 2012-06-30 | 26.84% |
| 2012-03-31 | 25.91% |
| 2011-12-31 | 17.24% |
| 2011-09-30 | 25.85% |
| 2011-06-30 | 22.78% |
| 2011-03-31 | 26.64% |
| 2010-12-31 | 10.83% |
| 2010-09-30 | 28.15% |
| 2010-06-30 | 21.57% |
| 2010-03-31 | 27.67% |
| 2009-12-31 | 21.54% |
| 2009-09-30 | 20.91% |
| 2009-06-30 | 29.07% |
| 2009-03-31 | 28.19% |
| 2008-12-31 | 23.27% |
| 2008-09-30 | 22.09% |
| 2008-06-30 | 28.57% |
| 2008-03-31 | 31.31% |
| 2007-12-31 | 32.78% |
| 2007-09-30 | 13.95% |
| 2007-06-30 | 33.23% |
| 2007-03-31 | 34.43% |
| 2006-12-31 | 36.24% |
| 2006-09-30 | 31.04% |
| 2006-06-30 | 31.98% |
| 2006-03-31 | 33.76% |
| 2005-12-31 | 33.13% |
| 2005-09-30 | 31.55% |
| 2005-06-30 | 32.57% |
| 2005-03-31 | 31.09% |
| 2004-12-31 | 30.16% |
| 2004-09-30 | 27.42% |
| 2004-06-30 | 23.84% |
| 2004-03-31 | 20.72% |
| 2003-12-31 | 9.34% |
| 2003-09-30 | 32.27% |
| 2003-06-30 | 32.77% |
| 2003-03-31 | 31.27% |
| 2002-12-31 | 30.01% |
| 2002-09-30 | 29.07% |
